IFNGR1 and neoplasm: Tumor cells insensitive to IFNγ due to a mutant IFNγ receptor (IFNGR1), grew more aggressively when transplanted into a wild type host (63), but when those cells were made responsive again by complementation with a wild type IFNGR1, they became highly immunogenic and failed to form tumors in the recipients (64).